Literature DB >> 1448050

[A role of interpectoral (Rotter's) lymph node dissection in modified radical mastectomy for breast cancer].

N Yamasaki1, H Kodama.   

Abstract

To study the influence of interpectoral lymph node (IPN) dissection on the prognosis of patients who underwent modified radical mastectomy, IPN was carefully dissected and studied pathologically on 168 cases of our breast cancer patients operated with modified radical mastectomy. There were 1.2 lymph nodes on an average in the interpectoral region, and they were almost 1-2mm in diameter. IPN metastases were found in 10 cases. (Tis: 0%, Stage I: 4.9%, Stage II: 5.7%, Stage III: 13%). Tumors located in outer quadrant in almost all these cases. Positive IPN were found in 6 (16%) of n1 alpha group, 1 (10%) of n1 beta group, and in 3 (50%) of n2 group. All these 3 cases of n2 died of distant metastasis and local recurrence. Two (1.7%) of axillary node (1a, 1b) negative patients had microinvolvement of cancer only in IPN, and are currently disease-free. These data suggest that IPN metastasis may occur even in the early breast cancer patients, and that may be controllable by lymph node excision. Therefore, routine and careful dissection of IPN through wide opening of sulcus interpectoralis is necessary for modified radical mastectomy and even for breast preserving operation.

Entities:  

Mesh:

Year:  1992        PMID: 1448050

Source DB:  PubMed          Journal:  Nihon Geka Gakkai Zasshi        ISSN: 0301-4894


  2 in total

1.  Prognostic value of the interpectoral lymph nodes in breast cancer. A 20-year survival study.

Authors:  A García-Vilanova Comas; A García Vilanova; E Fuster-Diana; N Martínez-Alzamora; Jm Fernández-Tena; J García-Vilanova Comas; M García-Vilanova Comas
Journal:  Clin Transl Oncol       Date:  2006-02       Impact factor: 3.405

2.  Rotter's Lymph Nodes-Do We Really Need to Remove During Axillary Clearance?

Authors:  Arun Gowda Keelara; C Satish; H K Rudresh; K Harish; A S Kapali
Journal:  Indian J Surg Oncol       Date:  2021-04-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.